• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半乳糖模拟的1H-(1,2,3-三唑-1-基)甘露糖苷作为选择性半乳糖凝集素-3和9N抑制剂的合成。

Synthesis of galactose-mimicking 1H-(1,2,3-triazol-1-yl)-mannosides as selective galectin-3 and 9N inhibitors.

作者信息

Tejler Johan, Skogman Fredrik, Leffler Hakon, Nilsson Ulf J

机构信息

Organic Chemistry, Lund University, PO Box 124, SE-221 00 Lund, Sweden.

出版信息

Carbohydr Res. 2007 Sep 3;342(12-13):1869-75. doi: 10.1016/j.carres.2007.03.012. Epub 2007 Mar 14.

DOI:10.1016/j.carres.2007.03.012
PMID:17407769
Abstract

1H-[1,2,3]-Triazol-1-yl mannosides have been synthesized as inhibitors for the beta-galactoside-binding family of galectin proteins. Easier synthetic access to C1 in mannose, as compared to C3 in galactose, for attachment of affinity-enhancing triazoles rendered a synthetic advantage. The best mannose-derived inhibitor for galectin-9N, 4-benzylaminocarbonyl-1H-[1,2,3]-triazol-1-yl beta-D-mannopyranoside, had a Kd value of 540 microM, which compares favorably with its galactoside counterpart (Kd=670 microM) and with LacNAc (Kd=500 microM).

摘要

1H-[1,2,3] -三唑-1-基甘露糖苷已被合成作为半乳糖凝集素蛋白β-半乳糖苷结合家族的抑制剂。与半乳糖中的C3相比,甘露糖中C1更容易进行合成,便于连接增强亲和力的三唑,这带来了合成优势。半乳糖凝集素-9N的最佳甘露糖衍生抑制剂4-苄基氨基羰基-1H-[1,2,3] -三唑-1-基β-D-甘露吡喃糖苷的解离常数(Kd)值为540微摩尔,与对应的半乳糖苷(Kd = 670微摩尔)和乳糖-N-乙酰基神经氨酸(Kd = 500微摩尔)相比具有优势。

相似文献

1
Synthesis of galactose-mimicking 1H-(1,2,3-triazol-1-yl)-mannosides as selective galectin-3 and 9N inhibitors.半乳糖模拟的1H-(1,2,3-三唑-1-基)甘露糖苷作为选择性半乳糖凝集素-3和9N抑制剂的合成。
Carbohydr Res. 2007 Sep 3;342(12-13):1869-75. doi: 10.1016/j.carres.2007.03.012. Epub 2007 Mar 14.
2
1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors.1H-1,2,3-三唑-1-基硫代半乳糖苷衍生物作为高亲和力半乳糖凝集素-3 抑制剂。
Bioorg Med Chem. 2010 Jul 15;18(14):5367-78. doi: 10.1016/j.bmc.2010.05.040. Epub 2010 May 20.
3
Synthesis of O-galactosyl aldoximes as potent LacNAc-mimetic galectin-3 inhibitors.作为强效模拟乳糖-N-乙酰基葡糖胺的半乳糖凝集素-3抑制剂的O-半乳糖基醛肟的合成。
Bioorg Med Chem Lett. 2005 May 2;15(9):2343-5. doi: 10.1016/j.bmcl.2005.02.079.
4
Fragment-based development of triazole-substituted O-galactosyl aldoximes with fragment-induced affinity and selectivity for galectin-3.基于片段的三唑取代的O-半乳糖基醛肟的开发,具有片段诱导的对半乳糖凝集素-3的亲和力和选择性。
Org Biomol Chem. 2009 Oct 7;7(19):3982-90. doi: 10.1039/b909091f. Epub 2009 Jul 20.
5
3-(1,2,3-Triazol-1-yl)-1-thio-galactosides as small, efficient, and hydrolytically stable inhibitors of galectin-3.3-(1,2,3-三唑-1-基)-1-硫代半乳糖苷作为半乳糖凝集素-3的小型、高效且水解稳定的抑制剂。
Bioorg Med Chem Lett. 2005 Jul 15;15(14):3344-6. doi: 10.1016/j.bmcl.2005.05.084.
6
Synthesis of a phenyl thio-beta-D-galactopyranoside library from 1,5-difluoro-2,4-dinitrobenzene: discovery of efficient and selective monosaccharide inhibitors of galectin-7.由1,5-二氟-2,4-二硝基苯合成苯基硫代-β-D-吡喃半乳糖苷文库:发现高效且选择性的半乳糖凝集素-7单糖抑制剂
Org Biomol Chem. 2005 May 21;3(10):1922-32. doi: 10.1039/b502354h. Epub 2005 Apr 14.
7
Arginine binding motifs: design and synthesis of galactose-derived arginine tweezers as galectin-3 inhibitors.精氨酸结合基序:作为半乳糖凝集素-3抑制剂的半乳糖衍生精氨酸镊子的设计与合成
J Med Chem. 2008 Apr 10;51(7):2297-301. doi: 10.1021/jm701266y. Epub 2008 Mar 5.
8
Carbohydrate triazoles and isoxazoles as inhibitors of galectins-1 and -3.作为半乳糖凝集素-1和-3抑制剂的碳水化合物三唑和异恶唑
Chem Commun (Camb). 2006 Jun 14(22):2379-81. doi: 10.1039/b517529a. Epub 2006 Mar 16.
9
Structural and thermodynamic studies on cation-Pi interactions in lectin-ligand complexes: high-affinity galectin-3 inhibitors through fine-tuning of an arginine-arene interaction.凝集素-配体复合物中阳离子-π相互作用的结构和热力学研究:通过精调精氨酸-芳烃相互作用获得高亲和力的半乳糖凝集素-3抑制剂
J Am Chem Soc. 2005 Feb 16;127(6):1737-43. doi: 10.1021/ja043475p.
10
Screening for galectin-3 inhibitors from synthetic lacto-N-biose libraries using microscale affinity chromatography coupled to mass spectrometry.使用微尺度亲和色谱联用质谱从合成乳糖-N-二糖文库中筛选半乳糖凝集素-3抑制剂。
J Org Chem. 2006 Sep 15;71(19):7146-54. doi: 10.1021/jo060485v.

引用本文的文献

1
Targeting galectin-driven regulatory circuits in cancer and fibrosis.靶向癌症和纤维化中半乳糖凝集素驱动的调控通路
Nat Rev Drug Discov. 2023 Apr;22(4):295-316. doi: 10.1038/s41573-023-00636-2. Epub 2023 Feb 9.
2
Inhibition of galectins in cancer: Biological challenges for their clinical application.抑制癌症中的半乳糖凝集素:其临床应用的生物学挑战。
Front Immunol. 2023 Jan 10;13:1104625. doi: 10.3389/fimmu.2022.1104625. eCollection 2022.
3
Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: studies.
了解半乳糖凝集素抑制剂作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白潜在候选物的作用:研究。
RSC Adv. 2020 Aug 13;10(50):29873-29884. doi: 10.1039/d0ra04795c. eCollection 2020 Aug 10.
4
Synthesis of tricyclic carbohydrate-benzene hybrids as selective inhibitors of galectin-1 and galectin-8 N-terminal domains.三环碳水化合物-苯杂化物作为半乳糖凝集素-1和半乳糖凝集素-8 N端结构域选择性抑制剂的合成
RSC Adv. 2020 May 22;10(33):19636-19642. doi: 10.1039/d0ra03144e. eCollection 2020 May 20.
5
Synthetic glycoconjugates inhibitors of tumor-related galectin-3: an update.肿瘤相关半乳糖凝集素-3的合成糖缀合物抑制剂:最新进展
Glycoconj J. 2016 Dec;33(6):853-876. doi: 10.1007/s10719-016-9721-z. Epub 2016 Aug 15.
6
'Click chemistry' synthesis of 1-(α-D-mannopyranosyl)-1,2,3-triazoles for inhibition of α-mannosidases.用于抑制α-甘露糖苷酶的1-(α-D-吡喃甘露糖基)-1,2,3-三唑的“点击化学”合成
Carbohydr Res. 2015 Apr 10;406:34-40. doi: 10.1016/j.carres.2015.01.004. Epub 2015 Jan 19.
7
The inhibitory effects of a rhamnogalacturonan I (RG-I) domain from ginseng pectin on galectin-3 and its structure-activity relationship.人参果胶中鼠李半乳糖醛酸聚糖 I(RG-I)结构域对半乳糖凝集素-3 的抑制作用及其构效关系。
J Biol Chem. 2013 Nov 22;288(47):33953-33965. doi: 10.1074/jbc.M113.482315. Epub 2013 Oct 7.
8
Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine.合成 TF 抗原模拟物/半乳糖凝集素-3 抑制剂乳果糖-L-亮氨酸抑制前列腺癌骨转移。
Neoplasia. 2012 Jan;14(1):65-73. doi: 10.1593/neo.111544.
9
Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection.半乳糖凝集素-1 特异性抑制剂作为一类新的化合物治疗 HIV-1 感染。
Antimicrob Agents Chemother. 2012 Jan;56(1):154-62. doi: 10.1128/AAC.05595-11. Epub 2011 Nov 7.
10
Structural basis for distinct binding properties of the human galectins to Thomsen-Friedenreich antigen.人半乳糖凝集素与汤姆森-弗里登赖希抗原结合特性差异的结构基础。
PLoS One. 2011;6(9):e25007. doi: 10.1371/journal.pone.0025007. Epub 2011 Sep 20.